Patterns of use and outcomes in patients treated with etravirine in the HIV research network

Kelly Gebo, Cindy Voss, Joseph Mrus

Research output: Contribution to journalArticle

Abstract

This observational analysis examined the clinical outcomes of patients receiving etravirine-(ETR-) based therapy, particularly with protease inhibitors (PIs) other than darunavir (DRV) and with raltegravir (RAL). Data included treatment-experienced adults in the HIV Research Network who began ETR-containing antiretroviral regimens in 2008-2010. The primary objective was to assess 6-month outcomes (durability, i.e., still on an ETR-containing regimen; change in CD4+ cell count and HIV-1 RNA

Original languageEnglish (US)
Article number492831
JournalAIDS Research and Treatment
Volume2013
DOIs
StatePublished - 2013

Fingerprint

etravirine
HIV
CD4 Lymphocyte Count
Protease Inhibitors
Research
HIV-1
RNA
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology and Allergy
  • Infectious Diseases
  • Dermatology

Cite this

Patterns of use and outcomes in patients treated with etravirine in the HIV research network. / Gebo, Kelly; Voss, Cindy; Mrus, Joseph.

In: AIDS Research and Treatment, Vol. 2013, 492831, 2013.

Research output: Contribution to journalArticle

@article{06211ba575fe4405a86bc66e9aec4c6d,
title = "Patterns of use and outcomes in patients treated with etravirine in the HIV research network",
abstract = "This observational analysis examined the clinical outcomes of patients receiving etravirine-(ETR-) based therapy, particularly with protease inhibitors (PIs) other than darunavir (DRV) and with raltegravir (RAL). Data included treatment-experienced adults in the HIV Research Network who began ETR-containing antiretroviral regimens in 2008-2010. The primary objective was to assess 6-month outcomes (durability, i.e., still on an ETR-containing regimen; change in CD4+ cell count and HIV-1 RNA",
author = "Kelly Gebo and Cindy Voss and Joseph Mrus",
year = "2013",
doi = "10.1155/2013/492831",
language = "English (US)",
volume = "2013",
journal = "AIDS Research and Treatment",
issn = "2090-1240",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Patterns of use and outcomes in patients treated with etravirine in the HIV research network

AU - Gebo, Kelly

AU - Voss, Cindy

AU - Mrus, Joseph

PY - 2013

Y1 - 2013

N2 - This observational analysis examined the clinical outcomes of patients receiving etravirine-(ETR-) based therapy, particularly with protease inhibitors (PIs) other than darunavir (DRV) and with raltegravir (RAL). Data included treatment-experienced adults in the HIV Research Network who began ETR-containing antiretroviral regimens in 2008-2010. The primary objective was to assess 6-month outcomes (durability, i.e., still on an ETR-containing regimen; change in CD4+ cell count and HIV-1 RNA

AB - This observational analysis examined the clinical outcomes of patients receiving etravirine-(ETR-) based therapy, particularly with protease inhibitors (PIs) other than darunavir (DRV) and with raltegravir (RAL). Data included treatment-experienced adults in the HIV Research Network who began ETR-containing antiretroviral regimens in 2008-2010. The primary objective was to assess 6-month outcomes (durability, i.e., still on an ETR-containing regimen; change in CD4+ cell count and HIV-1 RNA

UR - http://www.scopus.com/inward/record.url?scp=84874628000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874628000&partnerID=8YFLogxK

U2 - 10.1155/2013/492831

DO - 10.1155/2013/492831

M3 - Article

VL - 2013

JO - AIDS Research and Treatment

JF - AIDS Research and Treatment

SN - 2090-1240

M1 - 492831

ER -